Skip to Main Content

Paper Details

Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
JAMA Netw Open
90
2021
C-reactive protein, COVID-19, D-dimer, Participants, Patients, Remdesivir, alanine, alanine aminotransferase, albumin, coronavirus, coronavirus 2 infection, coronavirus disease 2019, dimerized, lymphocyte, men, oxygen, patient, patients, plasmin fragment D, remdesivir, severe acute respiratory syndrome, white blood cell
Author NameAffiliation
Brian T GaribaldiJohns Hopkins University School of Medicine
Scott L ZegerJohns Hopkins Bloomberg School of Public Health
George Caleb AlexanderCenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health
Yanxun XuJohns Hopkins University
Yanxun XuDivision of Biostatistics and Bioinformatics at The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
  • 1 - 5

Datasets

Release 1.2